Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advancing a vaccine to prevent human schistosomiasis
Maureen Merrifield, Peter J. Hotez, Coreen M. Beaumier, et al.
Vaccine (2016) Vol. 34, Iss. 26, pp. 2988-2991
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Schistosomiasis
Philip T. LoVerde
Advances in experimental medicine and biology (2019), pp. 45-70
Closed Access | Times Cited: 148
Schistosomiasis vaccines: where do we stand?
Biniam Mathewos Tebeje, Marina Harvie, Hong You, et al.
Parasites & Vectors (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 138
Schistosomiasis: Drugs used and treatment strategies
Lidiany da Paixão Siqueira, Danilo Augusto Ferreira Fontes, Cindy Siqueira Britto Aguilera, et al.
Acta Tropica (2017) Vol. 176, pp. 179-187
Closed Access | Times Cited: 115
A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics
Marijke C. C. Langenberg, Marie-Astrid Hoogerwerf, Jan Pieter R. Koopman, et al.
Nature Medicine (2020) Vol. 26, Iss. 3, pp. 326-332
Open Access | Times Cited: 106
The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game
Paul Ogongo, Ruth Nyakundi, Gerald K. Chege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 43
History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination
Langui Song, Xiaoying Wu, Moussa Sacko, et al.
Parasitology Research (2016) Vol. 115, Iss. 11, pp. 4071-4081
Closed Access | Times Cited: 73
Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
Maria João Gouveia, Paul J. Brindley, Fátima Gärtner, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 1, pp. 15-15
Open Access | Times Cited: 72
Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials
Afzal A. Siddiqui, SABRINA SIDDIQUI
Trends in Parasitology (2016) Vol. 33, Iss. 3, pp. 194-201
Open Access | Times Cited: 66
Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomes in sub-Saharan Africa: a systematic review
Muhubiri Kabuyaya, Moses John Chimbari, Samson Mukaratirwa
Infectious Diseases of Poverty (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 65
Metazoan Parasite Vaccines: Present Status and Future Prospects
Christian Stutzer, Sabine A. Richards, M.F.Carvalho Ferreira, et al.
Frontiers in Cellular and Infection Microbiology (2018) Vol. 8
Open Access | Times Cited: 64
Schistosomiasis and hookworm infection in humans: Disease burden, pathobiology and anthelmintic vaccines
A Anisuzzaman, Naotoshi Tsuji
Parasitology International (2020) Vol. 75, pp. 102051-102051
Closed Access | Times Cited: 64
Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is (“Isolate–Inactivate–Inject”) Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview
Nicola Luigi Bragazzi, Vincenza Gianfredi, Milena Villarini, et al.
Frontiers in Public Health (2018) Vol. 6
Open Access | Times Cited: 62
Whole-genome sequence of the bovine blood fluke Schistosoma bovis supports interspecific hybridization with S. haematobium
Harald Oey, Martha Zakrzewski, Kerstin Gravermann, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 1, pp. e1007513-e1007513
Open Access | Times Cited: 59
A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
Arif Jamal Siddiqui, Jyoti Bhardwaj, Juhi Saxena, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 792-792
Open Access | Times Cited: 18
Vaccines for epidemic infections and the role of CEPI
Stanley A. Plotkin
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 12, pp. 2755-2762
Open Access | Times Cited: 53
A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area
W Keitel, Gail E. Potter, David Diemert, et al.
Vaccine (2019) Vol. 37, Iss. 43, pp. 6500-6509
Open Access | Times Cited: 53
Vaccination of hamsters with Opisthorchis viverrini extracellular vesicles and vesicle-derived recombinant tetraspanins induces antibodies that block vesicle uptake by cholangiocytes and reduce parasite burden after challenge infection
Sujittra Chaiyadet, Javier Sotillo, Watchara Krueajampa, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 5, pp. e0007450-e0007450
Open Access | Times Cited: 51
Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase
Hatem Tallima, Jan Dvořák, Sahira Kareem, et al.
PLoS neglected tropical diseases (2017) Vol. 11, Iss. 3, pp. e0005443-e0005443
Open Access | Times Cited: 50
Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics
Daniel Sepúlveda‐Crespo, Rosa M. Reguera, F.A. Rojo-Vázquez, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 1715-1753
Closed Access | Times Cited: 40
Onchocerca volvulus: The Road from Basic Biology to a Vaccine
Sara Lustigman, Benjamin L. Makepeace, Thomas R. Klei, et al.
Trends in Parasitology (2017) Vol. 34, Iss. 1, pp. 64-79
Open Access | Times Cited: 43
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders’ meeting held in Entebbe, Uganda.
Alison M. Elliott, Meta Roestenberg, Anne Wajja, et al.
AAS Open Research (2018) Vol. 1, pp. 2-2
Open Access | Times Cited: 43
Are public-private partnerships the solution to tackle neglected tropical diseases? A systematic review of the literature
Céline Aerts, Temmy Sunyoto, Fabrizio Tediosi, et al.
Health Policy (2017) Vol. 121, Iss. 7, pp. 745-754
Open Access | Times Cited: 42
Opisthorchis viverrini Proteome and Host–Parasite Interactions
Sutas Suttiprapa, Javier Sotillo, Michael J. Smout, et al.
Advances in Parasitology/Advances in parasitology (2018), pp. 45-72
Closed Access | Times Cited: 39
Current status and future prospects of protein vaccine candidates against Schistosoma mansoni infection
Tahir Eyayu, Ayalew Jejaw Zeleke, Ligabaw Worku
Parasite Epidemiology and Control (2020) Vol. 11, pp. e00176-e00176
Open Access | Times Cited: 39
In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
Javier Sotillo, Mark Pearson, Luke Becker, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 5, pp. e0007362-e0007362
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top